Inventia Healthcare recalls over 13,000 bottles of chlorthalidone tablets
सिर्फ तथ्य

Inventia Healthcare recalls over 13,000 bottles of chlorthalidone tablets

सारांश

The FDA classified the recall of Inventia Healthcare's 25-mg chlorthalidone tablets as a Class II action after quality tests showed the tablets did not dissolve properly.

The U.S. Food and Drug Administration announced a nationwide recall of 13,567 bottles of 25-milligram chlorthalidone tablets manufactured by India-based Inventia Healthcare Ltd. The recall, initiated in September, was prompted by testing that indicated the tablets failed to dissolve as required.

Each bottle contains 100 tablets and bears the National Drug Code 64980-599-01 with an expiration date of April 2027. Chlorthalidone is commonly prescribed to manage high blood pressure and fluid retention.

The FDA designated the recall as a Class II event, meaning exposure to the product could cause temporary or medically reversible health effects, though the likelihood of serious consequences is considered remote.

Inventia Healthcare had previously recalled more than 11,400 bottles of the same medication in June for similar dissolution problems. The agency has not reported any injuries linked to the defect, and the company has not provided a comment to date.

स्रोत

Fox Business

पढ़ते रहें — निःशुल्क

समाचार फ़ॉलो करने के लिए मुफ़्त खाता बनाएँ। कार्ड की आवश्यकता नहीं।